FOXD2 and laryngeal carcinoma: To define the expression pattern of lncRNA FOXD2-AS1 in laryngeal cancer, we first analyzed the mRNA expression levels of FOXD2-AS1 in head and neck cancer, as well as in normal tissues using a dataset from The Cancer Genome Atlas (TCGA), containing 26% of tumors from laryngeal sites, using UALCAN webserver (http://ualcan.path.uab.edu/index.html).